mtl advanced Revenue and Competitors

Rotherham, UK

Location

N/A

Total Funding

Engineering

Industry

Estimated Revenue & Valuation

  • mtl advanced's estimated annual revenue is currently $16.8M per year.(i)
  • mtl advanced's estimated revenue per employee is $110,000

Employee Data

  • mtl advanced has 153 Employees.(i)
  • mtl advanced grew their employee count by 9% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$20.7M1886%N/AN/A
#2
$6.3M704%N/AN/A
#3
$8.9M8924%N/AN/A
#4
$42.9M34336%N/AN/A
#5
$2.7M34-26%N/AN/A
#6
$3.9M49-4%N/AN/A
#7
$3.1M39-15%N/AN/A
#8
$5.4M6011%N/AN/A
#9
$6.7M7432%N/AN/A
#10
$42.6M3415%N/AN/A
Add Company

What Is mtl advanced?

mtl advanced ltd is a well invested project manufacturing company partnered with WEC Group, specialising in the supply of components, ranging from precision cut parts to high integrity machined fabrications. \r\n\r\nWe are a key supplier to various sectors including: defence, offshore, construction, quarrying and recycling. \r\n\r\nOur Rotherham manufacturing facility includes: laser cutting, high definition plasma cutting, waterjet cutting, CNC machining, gas profile cutting & fabrication with robotic, semi automated, & manual welding stations.\r\n\r\nWe work with many OEMs such as BAE Systems, Caterpillar & Sandvik.

keywords:N/A

N/A

Total Funding

153

Number of Employees

$16.8M

Revenue (est)

9%

Employee Growth %

N/A

Valuation

N/A

Accelerator

mtl advanced News

2022-04-17 - Advanced High-Strength Steel Market Size, Outlook And ...

Tata Steel Limited, ArcelorMittal S.A., NanoSteel, AK Steel Corporation, Nucor Corporation, MTL Advanced Ltd., United States Steel...

2022-04-06 - MiNA Therapeutics Presents Proof of Mechanism Data on ...

MTL?STING is the second drug candidate to be advanced from MiNA's internal pipeline of RNAa therapeutics. MiNA's first drug candidate, MTL-CEBPA...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$53.6M16810%N/A
#2
$38.4M194-3%N/A
#3
$67.9M21312%N/A
#4
$15M3145%N/A
#5
$72.9M3246%N/A